154 related articles for article (PubMed ID: 11214692)
1. The significance of recurrent lung opacities in neonates on surfactant treatment for respiratory distress syndrome.
Odita JC
Pediatr Radiol; 2001 Feb; 31(2):87-91. PubMed ID: 11214692
[TBL] [Abstract][Full Text] [Related]
2. Respiratory distress syndrome treated with human surfactant: radiographic findings.
Edwards DK; Hilton SV; Merritt TA; Hallman M; Mannino F; Boynton BR
Radiology; 1985 Nov; 157(2):329-34. PubMed ID: 3840268
[TBL] [Abstract][Full Text] [Related]
3. Findings on chest radiographs after prophylactic pulmonary surfactant treatment of premature infants.
Clarke EA; Siegle RL; Gong AK
AJR Am J Roentgenol; 1989 Oct; 153(4):799-802. PubMed ID: 2773736
[TBL] [Abstract][Full Text] [Related]
4. Surfactant replacement therapy with a single postventilatory dose of a reconstituted bovine surfactant in preterm neonates with respiratory distress syndrome: final analysis of a multicenter, double-blind, randomized trial and comparison with similar trials. The Surfactant-TA Study Group.
Fujiwara T; Konishi M; Chida S; Okuyama K; Ogawa Y; Takeuchi Y; Nishida H; Kito H; Fujimura M; Nakamura H
Pediatrics; 1990 Nov; 86(5):753-64. PubMed ID: 2235230
[TBL] [Abstract][Full Text] [Related]
5. Short-term outcome of pulmonary hemorrhage in very-low-birth-weight preterm infants.
Yen TA; Wang CC; Hsieh WS; Chou HC; Chen CY; Tsao PN
Pediatr Neonatol; 2013 Oct; 54(5):330-4. PubMed ID: 23711674
[TBL] [Abstract][Full Text] [Related]
6. [Clinical characteristics and outcomes of respiratory distress syndrome in term and late-preterm neonates].
Chen A; Shi LP; Zheng JY; Du LZ
Zhonghua Er Ke Za Zhi; 2008 Sep; 46(9):654-7. PubMed ID: 19099850
[TBL] [Abstract][Full Text] [Related]
7. Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.
Bassler D
Neonatology; 2015; 107(4):358-9. PubMed ID: 26044104
[TBL] [Abstract][Full Text] [Related]
8. Radiological changes after therapeutic use of surfactant in infants with respiratory distress syndrome.
Dinger J; Schwarze R; Rupprecht E
Pediatr Radiol; 1997 Jan; 27(1):26-31. PubMed ID: 8995163
[TBL] [Abstract][Full Text] [Related]
9. [The clinical comparative study of preterm respiratory distress syndrome and transient tachypnea of newborn].
Liu S; Tong X
Zhonghua Er Ke Za Zhi; 2015 Feb; 53(2):104-8. PubMed ID: 25876684
[TBL] [Abstract][Full Text] [Related]
10. A multicenter, randomized, controlled trial of lucinactant versus poractant alfa among very premature infants at high risk for respiratory distress syndrome.
Sinha SK; Lacaze-Masmonteil T; Valls i Soler A; Wiswell TE; Gadzinowski J; Hajdu J; Bernstein G; Sanchez-Luna M; Segal R; Schaber CJ; Massaro J; d'Agostino R;
Pediatrics; 2005 Apr; 115(4):1030-8. PubMed ID: 15805381
[TBL] [Abstract][Full Text] [Related]
11. [Effect of natural surfactant on mortality and morbidity in neonates with a birth weight below 1500 grams].
Stranák Z; Janota J; Miletín J; Simák J
Ceska Gynekol; 2000 Dec; 65 Suppl 1():38-42. PubMed ID: 11394231
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary Surfactant Replacement Therapy for Respiratory Distress Syndrome in Neonates: a Nationwide Epidemiological Study in Korea.
Shin JE; Yoon SJ; Lim J; Han J; Eun HS; Park MS; Park KI; Lee SM
J Korean Med Sci; 2020 Aug; 35(32):e253. PubMed ID: 32808509
[TBL] [Abstract][Full Text] [Related]
13. Surfactant treatment in premature infants with Respiratory Distress Syndrome in Curaçao.
Verhagen AA; Keli SO; van der Meulen GN; Wiersma H; Arias M; Angelista IR; Muskiet FD
West Indian Med J; 2001 Jun; 50(2):117-22. PubMed ID: 11677907
[TBL] [Abstract][Full Text] [Related]
14. Compare severity of bronchopulmonary dysplasia in neonates with respiratory distress syndrome treated with surfactant to without surfactant.
Chotigeat U; Ratchatanorravut S; Kanjanapattanakul W
J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S35-40. PubMed ID: 22043752
[TBL] [Abstract][Full Text] [Related]
15. From the archives of the AFIP: Lung disease in premature neonates: radiologic-pathologic correlation.
Agrons GA; Courtney SE; Stocker JT; Markowitz RI
Radiographics; 2005; 25(4):1047-73. PubMed ID: 16009823
[TBL] [Abstract][Full Text] [Related]
16. Chest radiographic course after exogenous surfactant therapy in baboons with respiratory distress syndrome.
Shimada S; Raju TN; Vidyasagar D; Maeta H; Bhat R
Crit Care Med; 1990 Sep; 18(9):969-73. PubMed ID: 2394121
[TBL] [Abstract][Full Text] [Related]
17. Chronic lung disease of the very low birth weight infant--is it preventable?
Ogawa Y
Turk J Pediatr; 1998; 40(1):35-44. PubMed ID: 9673527
[TBL] [Abstract][Full Text] [Related]
18. [Surfactant substitution in severe respiratory distress syndrome in premature infants weighing less than 1,000 g].
Speer CP; Harms K; Herting E; Müller F; Schröter W; Teichmann AT; Neumann N; Curstedt T; Robertson B
Geburtshilfe Frauenheilkd; 1990 May; 50(5):359-64. PubMed ID: 2197165
[TBL] [Abstract][Full Text] [Related]
19. Multicenter trial of single-dose modified bovine surfactant extract (Survanta) for prevention of respiratory distress syndrome. Ross Collaborative Surfactant Prevention Study Group.
Soll RF; Hoekstra RE; Fangman JJ; Corbet AJ; Adams JM; James LS; Schulze K; Oh W; Roberts JD; Dorst JP
Pediatrics; 1990 Jun; 85(6):1092-102. PubMed ID: 2187176
[TBL] [Abstract][Full Text] [Related]
20. Repeat surfactant therapy for postsurfactant slump.
Katz LA; Klein JM
J Perinatol; 2006 Jul; 26(7):414-22. PubMed ID: 16724122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
